![Stanford Peng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stanford Peng
Private Equity Investor chez
Frazier Management LLC
Profil
Stanford L.
Peng is currently a Venture Partner at Frazier Management LLC since 2025.
Former positions include President, Head-Research & Development at Alpine Immune Sciences, Inc. from 2019 to 2024; Chief Medical Officer & Head-Clinical Development at Stemcentrx, Inc. from 2015 to 2016; Executive Director-Medical at Seagen, Inc. from 2014 to 2015; Head-Rheumatology Clinical Research Unit at Benaroya Research Institute at Virginia Mason from 2009 to 2014; Senior Director at ARYx Therapeutics, Inc. from 2008 to 2009; and Assistant Professor at Washington University School of Medicine from 2002 to 2005.
Education includes undergraduate studies at Stanford University and a doctorate from Yale School of Medicine.
Postes actifs de Stanford Peng
| Sociétés | Poste | Début |
|---|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Private Equity Investor | 01/01/2025 |
Anciens postes connus de Stanford Peng
| Sociétés | Poste | Fin |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | President | 20/05/2024 |
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Directeur Technique/Scientifique/R&D | 01/01/2016 |
| SEAGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/2015 |
Benaroya Research Institute at Virginia Mason
 Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Operates medical research institute for autoimmune and immune system diseases | Directeur Technique/Scientifique/R&D | 01/01/2014 |
| ARYX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2009 |
Formation de Stanford Peng
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARYx Therapeutics, Inc.
 ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Benaroya Research Institute at Virginia Mason
Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Operates medical research institute for autoimmune and immune system diseases | Commercial Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
